36 employees
Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.
2020
$40M
from 3 investors over 3 rounds
Gennao Bio raised $40M on May 10, 2021
Investors: OrbiMed Advisors, Logos Global Management, LP and Surveyor Capital